In this FENS Friday webinar were discussed the challenges presented by the blood brain barrier to CNS biomarker discovery and use, the potential of extracellular vesicles as novel markers of brain function and dysfunction, and the clinical relevance of established and novel blood biomarkers of neuropsychiatric disorders and brain injury. The limitations of the use of blood-borne CNS biomarkers both in the laboratory and the clinic and provide insights into the future development of novel biomarkers of brain health and disease were also explored.

The webinar was organised by the FENS Committee for Higher Education and Training (CHET).